Due to the advent of consumer-directed healthcare, Intrepid’s Healthcare team is seeing meaningful changes develop in the key value attributes that distinguish premium-priced healthcare companies. As business owners and investors… Read more »
Private equity sponsors focused on healthcare seem to be searching for the next nascent physician specialty that is ripe for investment, consolidation, and growth. Based on our team’s dialogue with… Read more »
Intrepid’s Healthcare team recently attended the inaugural Autism Investor Summit, where Adam Abramowitz spoke on a panel titled: “How to Maximize Value in a Sale Process.” As the first-ever event exclusively focused on… Read more »
Earlier this month, Intrepid’s Healthcare team met with many of the healthcare leaders who made the pilgrimage to attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. After… Read more »
Intrepid’s Healthcare Group recently co-chaired a healthcare M&A Webinar with accounting firm RSM which highlighted best practices in preparing a healthcare business for a transaction. Panelists discussed perspectives from both… Read more »
We are in the midst of an unprecedented wave of healthcare mergers and acquisitions (M&A) activity. Please join us on Tuesday, December 4th for a webinar co-hosted by Intrepid and RSM,… Read more »
Intrepid’s Head of Healthcare, Jonathan Bluth is speaking at the upcoming ACG 2018 SoCal Capital Summit. Join Jonathan and other industry leaders on November 14 for a panel discussion on… Read more »
M&A continues to be a driver of change and innovation in the dynamic healthcare sector for both strategic acquirers looking to accelerate growth and private equity sponsors looking for their… Read more »
Earlier this week, Myriad Genetics (NASDAQ: MYGN) announced the acquisition of Counsyl for $375 million. This deal brings together a long-standing leader in hereditary cancer diagnostics with a highly-regarded start-up… Read more »